Citi Pharma Limited (PSX:CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
87.07
-1.50 (-1.69%)
At close: Mar 27, 2025

Citi Pharma Revenue

Citi Pharma had revenue of 3.53B PKR in the quarter ending December 31, 2024, with 7.92% growth. This brings the company's revenue in the last twelve months to 13.19B, up 8.11% year-over-year. In the fiscal year ending June 30, 2024, Citi Pharma had annual revenue of 12.41B with 0.10% growth.

Revenue (ttm)
13.19B
Revenue Growth
+8.11%
P/S Ratio
1.59
Revenue / Employee
25.42M
Employees
519
Market Cap
20.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202412.41B12.26M0.10%
Jun 30, 202312.40B2.62B26.76%
Jun 30, 20229.78B3.98B68.75%
Jun 30, 20215.80B2.27B64.29%
Jun 30, 20203.53B920.60M35.31%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition